This site is intended for health professionals only

Published on 23 November 2011

Share this story:

RELATED ARTICLES
Expert Comment: Normalising cancer-associated thrombosis
German hospital pharmacy forges ahead
Launch of the new Hospital Pharmacy Europe Mobile App
Moderate-intensity statin therapy with ezetimibe non-inferior to high-intensity mono-therapy
Severe vitamin D deficiency linked with higher mortality and longer hospital stay in sepsis

Understanding compassionate-use programmes

teaser

 

Prof Paola Minghetti, PhD  

Professor of Pharmaceutical Sciences, Universit



Most read

1
Feedback: Automation systems in your hospital
2
Merck agrees huge Vioxx settlement
3
Janssen-Cilag’s Stelara approved by NICE
4
Helapet introduce new, improved 20mm Vented Vial Adapter
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Review of zoledronic acid in the treatment of postmenopausal osteoporosis
No effect on outcome from additional MRI with CT scan in acute ischaemic stroke
First installation of Swisslog Pack-Picker in the UK
Fosaprepitant dimeglumine is non-inferior to aprepitant
Roche and Genentech remain committed to Avastin adjuvant programs